Ear device could ease gut woes in kids with bendy joint disorder
NCT ID NCT05212129
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing whether a small, battery-powered device worn on the ear can reduce gastrointestinal symptoms in children aged 10-18 with hypermobile Ehlers-Danlos syndrome (hEDS) and related autonomic nervous system problems. The device, called IB-Stim, delivers gentle electrical pulses to a nerve in the ear to stimulate the vagus nerve. Researchers will measure changes in stomach symptoms, gastric function, and body awareness over six weeks. The goal is to find a non-drug treatment for the common gut issues that accompany hEDS.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- percutaneous vagal nerve stimulation device (IB-Stim)
- What this could lead to
- If it works, this could offer a drug-free way to reduce stomach and bowel symptoms in children with hypermobile Ehlers-Danlos syndrome.
- What could go wrong
- This is an early-stage, open-label trial with no placebo group, so results may be influenced by expectation. The device is already FDA-approved for other uses, but its benefit for this specific condition is unproven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 90 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Apr 2021
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
10 to 18 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Children aged 10-18 years old * Children with functional upper GI complaints and clinical suspicion for hEDS or HSD as well as a Beighton score of at least 4/9 * Children with functional upper GI complaints and clinical suspicion for ANS dysfunction * De-identified data from our prior studies (IRB #689519 and IRB #1064187) of patients with functional GI disorders who do NOT meet criteria for hEDS will be used as a comparison group * Children who are English-speaking and lack other explanation for symptoms * Children willing to participate and consent to this study (for children, have a parent willing to participate) Exclusion Criteria: A) Exclusion Criteria applying to all participants: * Medically complex children or those who take a medication or suffer from a disease that can explain symptoms will be excluded from participation in the study. * Adult subjects, children or their parents who have significant developmental delay (will be excluded due to difficulties in accurately completing the questionnaires and assessing symptoms) * Patients with findings of organic disease such as peptic ulcer disease, H.pylori gastritis, celiac disease, inflammatory bowel disease, allergic disorders, metabolic disorder or any other chronic condition or medication that may cause chronic GI symptoms will be excluded from the study. * Patients who are treated with a new drug affecting the central nervous system in the two weeks prior to enrollment will also be excluded. * Pregnancy (evaluating MD screens patients as they normally would during a clinic visit (by questioning) and would only perform urine pregnancy test if clinically indicated (absence of menstrual period or other symptoms concerning for pregnancy) * Chronic alcohol/illicit drug use and/or smoking. B) Exclusion Criteria for subjects undergoing pVNS therapy: * Severe dermatological condition or active infection of external or middle ear * Implanted electrical device C) Exclusion Criteria for subjects undergoing aVNS therapy: * Hearing impaired * Sight impaired without correction * Seizure disorder D) Exclusion Criteria for subjects undergoing gastric motor function sub-study: * Patients with pacemakers, metal clips used in previous surgery or other device which are not compatible with MRI scanning * Claustrophobia or inability to lie still in the scanner * Orthodontic braces or permanent retainers * Patients who are unable to tolerate noise produced by the MRI * Egg allergy or anticipated inability to complete a standardized egg meal E) Exclusion Criteria for subjects undergoing HepGI Biobank specimen collection sub-study: * Bleeding disorder for the specific biopsies * Recent antibiotic usage for fecal sample * Significant anemia or clinical status which will not allow safe blood draw required for blood collection * Refusal of blood collection or to provide DNA sample * Inability or unwillingness on the individual (or parent/legal guardian) to provide clinical or family history.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Autonomic nervous system disease are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Medical College of Wisconsin
RECRUITINGMilwaukee, Wisconsin, 53226, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a High-Fat diet reset energy in long COVID?
- Scientists map the many faces of POTS to unlock better care
- Can tailored exercise help tame racing heart and fatigue after COVID?
- Could online pilates ease pain for those with stretchy joints?
- Can immune therapy IVIG calm long COVID's autonomic storm?
- Can stomach electricity reveal gut disease? new study investigates